Statistics for A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer
Total visits
| views | |
|---|---|
| A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer | 251 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:da09bb9c-cdb7-4ddd-85e1-e10ce694c551 | 4 |
Top country views
| views | |
|---|---|
| United States | 197 |
| Germany | 15 |
| Ukraine | 6 |
| Russia | 4 |
| Sweden | 4 |
| China | 3 |
| United Kingdom | 3 |
| Canada | 2 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 53 |
| Fairfield | 35 |
| Ann Arbor | 16 |
| Cambridge | 14 |
| Kiez | 14 |
| Houston | 13 |
| Jacksonville | 7 |
| Kiev | 6 |
| Chicago | 4 |
| San Francisco | 4 |
| Stockholm | 4 |
| Cherry Hill | 3 |
| Saint Petersburg | 3 |
| Seattle | 3 |
| Washington | 3 |
| Beijing | 2 |
| Brooklyn | 2 |
| Toronto | 2 |
| Gunzenhausen | 1 |
| Indianapolis | 1 |
| Moscow | 1 |
| Mountain View | 1 |
| Philadelphia | 1 |
| Seremban | 1 |
| Shanghai | 1 |
| Woburn | 1 |